MCRB earnings: a negative outcome, -35.3%

On November 2, 2023, Seres Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -35.3% in the window around the event. It had already run -29.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.